Variable | Before IPTW weighting | After IPTW weighting | ||||
---|---|---|---|---|---|---|
Levosimendan (n = 87) | Milrinone (n = 117) | Standardized difference | P value* | Standardized difference | P value** | |
Euroscore II | 3.81 | 2.12 | 0.35 | 0.02 | 0.17 | 0.86 |
NYHA category | 2.59 | 2.30 | 0.37 | 0.009 | 0.22 | 0.49 |
LV ejection fraction | 0.61 | 0.64 | − 0.28 | 0.05 | − 0.08 | 0.59 |
LV dilatation | 0.09 | 0.12 | − 0.09 | 0.52 | − 0.07 | 0.63 |
RV function altered | 0.39 | 0.21 | 0.33 | 0.02 | 0.08 | 0.61 |
RV hypertroph | 0.03 | 0.10 | − 0.27 | 0.05 | − 0.02 | 0.90 |
RV dilatation | 0.57 | 0.56 | 0.02 | 0.90 | 0.13 | 0.47 |
CPB duration | 183.23 | 114.60 | 0.97 | < 0.001 | − 0.05 | 0.82 |